Swiss biotech firm Alentis Therapeutics inks $105m Series C
Jeito Capital led the round with participation from other backers that included Novo Holdings A/S and RA Capital Management.
Jeito Capital led the round with participation from other backers that included Novo Holdings A/S and RA Capital Management.
Copyright PEI Media
Not for publication, email or dissemination